IL208027A0 - Methods, compositions, and kits for treating pain and pruritus - Google Patents

Methods, compositions, and kits for treating pain and pruritus

Info

Publication number
IL208027A0
IL208027A0 IL208027A IL20802710A IL208027A0 IL 208027 A0 IL208027 A0 IL 208027A0 IL 208027 A IL208027 A IL 208027A IL 20802710 A IL20802710 A IL 20802710A IL 208027 A0 IL208027 A0 IL 208027A0
Authority
IL
Israel
Prior art keywords
pruritus
kits
compositions
methods
treating pain
Prior art date
Application number
IL208027A
Other languages
English (en)
Original Assignee
Harvard College
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College, Gen Hospital Corp filed Critical Harvard College
Publication of IL208027A0 publication Critical patent/IL208027A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL208027A 2008-03-11 2010-09-07 Methods, compositions, and kits for treating pain and pruritus IL208027A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6901808P 2008-03-11 2008-03-11
PCT/US2009/001541 WO2009114139A2 (en) 2008-03-11 2009-03-11 Methods, compositions, and kits for treating pain and pruritis

Publications (1)

Publication Number Publication Date
IL208027A0 true IL208027A0 (en) 2010-12-30

Family

ID=41065720

Family Applications (1)

Application Number Title Priority Date Filing Date
IL208027A IL208027A0 (en) 2008-03-11 2010-09-07 Methods, compositions, and kits for treating pain and pruritus

Country Status (11)

Country Link
US (1) US20110086818A1 (enExample)
EP (1) EP2271329A4 (enExample)
JP (1) JP2011513484A (enExample)
KR (1) KR20110044166A (enExample)
CN (1) CN102112121A (enExample)
AU (1) AU2009223739A1 (enExample)
BR (1) BRPI0909627A2 (enExample)
CA (1) CA2717042A1 (enExample)
IL (1) IL208027A0 (enExample)
MX (1) MX2010009951A (enExample)
WO (1) WO2009114139A2 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2101819B1 (en) 2006-11-20 2013-01-09 President and Fellows of Harvard College Methods, compositions, and kits for treating pain and pruritis
WO2010085589A2 (en) 2009-01-22 2010-07-29 G&H Brands Llc Desensitizing drug product
EP2995303A1 (en) 2009-07-10 2016-03-16 President and Fellows of Harvard College Permanently charged sodium and calcium channel blockers as anti-inflammatory agents
JP5832856B2 (ja) * 2010-12-15 2015-12-16 久光製薬株式会社 局所鎮痛作用増強剤及び局所鎮痛キット
CN103547566B (zh) 2011-02-18 2017-05-31 阿萨纳生物科技有限责任公司 氨基茚满化合物及其治疗疼痛的用途
ES2596215T3 (es) 2011-10-24 2017-01-05 Asana Biosciences, Llc Ciclohexilaminas
US8779003B2 (en) 2011-12-29 2014-07-15 Mackay Memorial Hospital Method and composition for prolonging analgesic effect of local anesthetic
TWI603957B (zh) 2012-08-15 2017-11-01 阿沙納生物科學有限責任公司 胺基氫茚化合物用於治療膀胱過動症及間質性膀胱炎之用途
ES2675215T3 (es) 2013-02-08 2018-07-09 General Mills, Inc. Productos alimentarios reducidos en sodio
AU2015247815A1 (en) * 2014-04-14 2016-11-03 Flex Pharma, Inc. Ion channel activators and methods of use
WO2017024037A1 (en) * 2015-08-03 2017-02-09 President And Fellows Of Harvard College Charged ion channel blockers and methods for use
CN106214678B (zh) * 2016-07-26 2020-12-29 上海璃道医药科技有限公司 苯酮类药物的用途
US11253493B2 (en) 2017-01-23 2022-02-22 Cliff-Cartwright Corporation Compositions and methods affecting exercise performance
KR101877002B1 (ko) * 2017-03-06 2018-07-12 서울대학교 산학협력단 피라졸 유도체를 유효성분으로 함유하는 소양증의 예방 또는 치료용 약학적 조성물 및 이를 검출하기 위한 스크리닝 방법
KR101867779B1 (ko) * 2017-12-08 2018-06-19 서울대학교산학협력단 피라졸 유도체를 유효성분으로 함유하는 소양증의 예방 또는 치료용 약학적 조성물 및 이를 검출하기 위한 스크리닝 방법
WO2019144139A1 (en) * 2018-01-22 2019-07-25 Oregon State University Immunogenic compositions comprising mycobacterium bovis surface proteins and uses thereof
US12023332B2 (en) 2018-03-05 2024-07-02 Wylder Nation Foundation Compositions and methods for activating signaling through the CB1 cannabinoid receptor for treating and preventing diseases and disorders characterized by abnormal cellular accumulation of sphingolipids such as sphingomyelin
KR102954667B1 (ko) * 2018-08-15 2026-04-17 파마실 아베 치환된 벤즈아미드 및 치료법에서 이의 용도
CN109498604A (zh) * 2018-12-24 2019-03-22 复旦大学 香叶醇新用途,预防和治疗非疾病引起的瘙痒症的配制品及方法
BR112021017809A2 (pt) 2019-03-11 2021-11-23 Nocion Therapeutics Inc Bloqueadores de canais iônicos substituídos por éster e métodos para uso
US10786485B1 (en) 2019-03-11 2020-09-29 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
MA55307A (fr) 2019-03-11 2022-01-19 Nocion Therapeutics Inc Bloqueurs de canaux ioniques chargés et procédés d'utilisation
EP3937945A4 (en) * 2019-03-11 2023-01-04 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
WO2021091585A1 (en) 2019-11-06 2021-05-14 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10933055B1 (en) 2019-11-06 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US20230165812A1 (en) * 2020-02-27 2023-06-01 President And Fellows Of Harvard College Nociceptor neurons control cancer immunosurveillance
JP2023515874A (ja) * 2020-03-04 2023-04-14 ノイキュアズ,インコーポレーテッド Trpv1調節物質の投与に関連する交感神経興奮を防止するためのqx314の使用
US12162851B2 (en) 2020-03-11 2024-12-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
JP7708777B2 (ja) 2020-03-11 2025-07-15 ノシオン セラピューティクス,インコーポレイテッド 荷電したイオンチャンネル遮断薬および使用方法
CN113509457B (zh) * 2020-09-07 2023-03-21 四川昇嘉科技有限公司 山椒素在制备治疗湿疹的药物中的用途
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6413961B1 (en) * 1995-12-12 2002-07-02 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain and inflammation
MXPA02006051A (es) * 1999-12-15 2004-08-23 Ucb Farchim Sa Compuestos de amonio cuaternario ciclico.
WO2002089849A1 (en) * 2001-05-07 2002-11-14 Corium International Compositions and delivery systems for administration of a local anesthetic agent
EP1610742B1 (en) * 2003-04-10 2015-01-21 Neurogesx, Inc. Uses and compositions for administration of capsaicin
ES2223277B1 (es) * 2003-06-19 2006-03-01 Fernando Bouffard Fita Composicion anestesica para administracion topica.
EP1713450B1 (en) * 2004-01-30 2021-10-06 Corium, Inc. Rapidly dissolving film for delivery of an active agent
JP5148271B2 (ja) * 2004-06-02 2013-02-20 ニューロジズエックス,インコーポレーテッド 疼痛処置のためのカプサイシノイド、局所麻酔薬および/または鎮痒薬を含有する処方物
EP2101819B1 (en) * 2006-11-20 2013-01-09 President and Fellows of Harvard College Methods, compositions, and kits for treating pain and pruritis

Also Published As

Publication number Publication date
US20110086818A1 (en) 2011-04-14
WO2009114139A2 (en) 2009-09-17
AU2009223739A1 (en) 2009-09-17
WO2009114139A3 (en) 2009-12-23
KR20110044166A (ko) 2011-04-28
EP2271329A2 (en) 2011-01-12
EP2271329A4 (en) 2013-01-09
JP2011513484A (ja) 2011-04-28
CA2717042A1 (en) 2009-09-17
CN102112121A (zh) 2011-06-29
MX2010009951A (es) 2011-09-01
BRPI0909627A2 (pt) 2018-04-10

Similar Documents

Publication Publication Date Title
IL257418A (en) Methods for treating addiction
HRP20190214T1 (hr) Pripravci i metode za liječenje purpure
IL248652A0 (en) Methods, compositions and devices for facilitating re-creation
EP2271329A4 (en) METHOD, COMPOSITIONS AND SETS FOR TREATING PAIN AND PRURITIS
PL2894165T3 (pl) Sposoby i kompozycje do leczenia zaburzeń układu dopełniacza
ZA201101055B (en) Compositions and methods for treating osteoarthritis
IL202015A0 (en) Methods and compositions for treating skin conditions
IL210097A0 (en) Compositions and methods for treating unfluenza
EP2282826A4 (en) PROCESS FOR TREATMENT OF ODOR
IL212348A0 (en) Treatment method
EP2120561A4 (en) COMPOSITIONS FOR TREATING BIOFILMS, AND METHODS FOR THEIR USE
IL200889A0 (en) Compositions and kits for treating influenza
WO2012054862A9 (en) Agents, compositions, and methods for treating pruritis and related skin conditions
ZA201006293B (en) Composition and method for seed treatment use
EP2355660A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF MULTIPLE SCLEROSIS
EP2231185A4 (en) METHOD AND COMPOSITIONS FOR TREATING LIQUID TUMORS
ZA201106577B (en) Compounds and compositions for cognition-enhancement,methods of making,and methods of treating
EP2035015A4 (en) COMPOSITIONS, METHODS AND KITS FOR DRY EYE TREATMENT
GB0800570D0 (en) Composition, process for preparation and method of use
PL2318573T3 (pl) Sposób obróbki przeciwkorozyjnej
PL2262828T3 (pl) Kompozycje, sposoby i zestawy
ZA201101520B (en) Phenanthrenone compounds,compositions and methods
HK1151742A (en) Methods, compositions, and kits for treating pain and pruritis
ZA201000867B (en) Methods for treating dependence
HK1148947A (en) Method for treating addiction using quercetin-containing compositions